Stockreport

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) [Yahoo! Finance]

Traws Pharma, Inc.  (TRAW) 
PDF novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models " in the Nature Portfolio onl [Read more]